Our findings suggest that NOTCH3 downregulation may reverse the transcriptional repression of VIM to facilitate EMT in ESCC cells, leading to chemotherapy resistance and poor prognosis in ESCC patients. This evidence concerns the gene NOTCH3 and esophageal squamous cell carcinoma.